Evidence map›Paper›PMID 42393832›Full record

ArticleEndocrinology2026

Loss of the calorie restriction response protein DEPP1 worsens diet-induced obesity.

Sepideh Sheybani-Deloui, Kripa Shankar, Angie L Bookout, Juan A Rodriguez, Salil Varshney, Omprakash Singh, Connor Lawrence, Jake Tessnow, Aki Uchida, Deepali Gupta and 5 more

Abstract read
In one paragraph

Article in Endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Sepideh Sheybani-DelouiDepartment of Internal Medicine, Center for Hypothalamic Research, University of Texas Southwestern Medical Center, Dallas, TX 75390-9030, USA.ORCID 0000-0003-1434-8094
Kripa ShankarDepartment of Internal Medicine, Center for Hypothalamic Research, University of Texas Southwestern Medical Center, Dallas, TX 75390-9030, USA.
Angie L BookoutDepartment of Internal Medicine, Center for Hypothalamic Research, University of Texas Southwestern Medical Center, Dallas, TX 75390-9030, USA.
Juan A RodriguezDepartment of Internal Medicine, Center for Hypothalamic Research, University of Texas Southwestern Medical Center, Dallas, TX 75390-9030, USA.
Salil VarshneyDepartment of Internal Medicine, Center for Hypothalamic Research, University of Texas Southwestern Medical Center, Dallas, TX 75390-9030, USA.
Omprakash SinghDepartment of Internal Medicine, Center for Hypothalamic Research, University of Texas Southwestern Medical Center, Dallas, TX 75390-9030, USA.
Connor LawrenceDepartment of Internal Medicine, Center for Hypothalamic Research, University of Texas Southwestern Medical Center, Dallas, TX 75390-9030, USA.
Jake TessnowDepartment of Internal Medicine, Center for Hypothalamic Research, University of Texas Southwestern Medical Center, Dallas, TX 75390-9030, USA.
Aki UchidaDepartment of Internal Medicine, Center for Hypothalamic Research, University of Texas Southwestern Medical Center, Dallas, TX 75390-9030, USA.
Deepali GuptaDepartment of Internal Medicine, Center for Hypothalamic Research, University of Texas Southwestern Medical Center, Dallas, TX 75390-9030, USA.
Moyu LyuDepartment of Internal Medicine, Center for Hypothalamic Research, University of Texas Southwestern Medical Center, Dallas, TX 75390-9030, USA.
Avi W BursteinDepartment of Internal Medicine, Center for Hypothalamic Research, University of Texas Southwestern Medical Center, Dallas, TX 75390-9030, USA.
Shota TakemiDepartment of Internal Medicine, Center for Hypothalamic Research, University of Texas Southwestern Medical Center, Dallas, TX 75390-9030, USA.
Sherri Osborne-LawrenceDepartment of Internal Medicine, Center for Hypothalamic Research, University of Texas Southwestern Medical Center, Dallas, TX 75390-9030, USA.
Jeffrey M ZigmanDepartment of Internal Medicine, Center for Hypothalamic Research, University of Texas Southwestern Medical Center, Dallas, TX 75390-9030, USA.ORCID 0000-0003-3477-1295

Funding

UT Southwestern NORCP30DK127984 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI Jeffrey M Zigman · 2022 to 2026
$7.4M
Regulation of ghrelin secretion by the sympathetic nervous system (SNS)R01DK142092 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI Jeffrey M Zigman · 2025 to 2026
$1.3M
NIDDK NIH HHS P30 DK127984NIDDK NIH HHS R01 DK142092NIH HHS P30DK127984NIH HHS R01DK142092
6 · The paper itself

Abstract

The transcriptional landscape of the gastric mucosa in response to opposing nutritional states remains poorly defined. Here, we profiled gastric mucosal gene expression changes induced by diet-induced obesity (DIO) and calorie restriction (CR) in mice and investigated the physiological role of Decidual Protein Induced by Progesterone 1 (Depp1) using newly generated Depp1-knockout (KO) mice. RNA sequencing revealed that DIO elicits a predominantly proinflammatory transcriptional program in the gastric mucosa, whereas CR upregulates genes involved in peptide transport and extracellular matrix organization while downregulating immunity-related pathways. Among CR-induced genes, Depp1 exhibited the strongest positive correlation with expression of gene encoding the gastric hormone ghrelin. qRT-PCR confirmed enrichment of Depp1 in gastric ghrelin cells and demonstrated CR-induced upregulation of Depp1 in additional tissues, including liver, kidney, and pancreas; notably, hepatic induction by CR was absent in ghrelin-KO mice. Despite this association, Depp1-KO mice displayed normal metabolic responses to CR, including preserved glucose homeostasis. In contrast, following 16 weeks of ad libitum high-fat diet feeding, male Depp1-KO mice exhibited greater weight gain, hyperphagia, increased fat and lean mass, and impaired glucose tolerance compared with wild-type littermates. These phenotypes were accompanied by selective hepatic gene expression changes affecting Pgc1a, Pck1, and Igf1. Collectively, these findings identify Depp1 as a CR-induced, ghrelin-associated gene that influences hepatic transcriptional responses yet is dispensable for short-term adaptation to CR, while also implicating Depp1 as a protective factor against metabolic dysfunction during DIO through mechanisms that remain to be defined.

Indexed as

Caloric RestrictionObesityAnimalsDiet, High-FatGastric MucosaGhrelinLiverMaleMiceMice, Inbred C57BLMice, KnockoutGhrelincalorie restrictionDepp1diet-induced obesityghrelin

Identifiers

PMID42393832
PMCPMC13373476

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.